October 15th, 2025.

QUEBEC CITY--(BUSINESS WIRE)--Saguaro Biosciences, a pioneer in non-toxic live cell reagents for enhanced drug insights, announces a new distribution agreement with Bio-Techne Corporation (NASDAQ:TECH), a global provider of life science tools, reagents and diagnostic products. The partnership will leverage Bio-Techne’s extensive international sales and marketing channels to provide researchers worldwide with better access to Saguaro’s portfolio of non-toxic, wash-free dyes.

This strategic alliance is designed to meet the growing demand for advanced reagents that enable more physiologically relevant and high-throughput cell-based assays.

“This distribution agreement marks a significant milestone for Saguaro,” said Louis Turcotte, CEO and Co-Founder of Saguaro. “Bio-Techne’s reputation for quality and its global reach make them the ideal partner to bring our non-toxic dyes to a broader audience of researchers seeking better, more reliable data.”

Félix Lavoie-Pérusse, CCO and Co-Founder of Saguaro, added, “Our collaboration with Bio-Techne is a powerful validation of our technology. This partnership ensures that biotechs, academic labs, and large pharmaceutical companies, can seamlessly access our reagents, no matter where they are.”

Will Geist, President of Protein Sciences at Bio-Techne, added, “We are excited to leverage our extensive global distribution network to expand access to Saguaro Biosciences's innovative, non-toxic dyes. This partnership reinforces Bio-Techne's commitment to providing researchers with cutting-edge technology and meeting crucial needs in cell and gene therapy and 3D culture techniques.”

The partnership will initially focus on the distribution of Saguaro’s dyes, including ChromaLIVE™, the leading technology for drug profiling; NucleoLIVE™, a nuclear dye; and MortaLIVE™, a live-dead dye, which are designed for enhanced phenotypic profiling, cell viability, and cytotoxicity screening, respectively.

VIEW ORIGINAL ARTICLE